Skip to main content

Table 1 Baseline characteristics of the study population

From: Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus

Variable Controls (n = 68) Patients with T2DM (n = 148) p value
Demographics    
Age, year 56 ± 11 58 ± 12 0.16
Men/Women 45/23 95/53 0.72
Systolic BP, mm Hg 118 ± 11 126 ± 17 <0.001
Diastolic BP, mm Hg 71 ± 7 68 ± 10 <0.001
Heart rate, bpm 62 ± 9 71 ± 10 <0.001
Body mass index, kg/m2 22.6 ± 2.6 26.1 ± 5.5 <0.001
Body surface area, m2 1.66 ± 0.16 1.76 ± 0.38 0.002
Disease duration, months 0 121 ± 93  
 Waist/Hip ratio - 0.89 ± 0.20  
Comorbidity    
 Hypertension, n (%) 0 71 (48%)  
 Dyslipidemia, n (%) 0 93 (63%)  
 Cerebral vascular disease, n (%) 0 9 (6%)  
 ASO, n (%) 0 4 (3%)  
 Smoking, n (%) - 68 (46%)  
Medications 0 101 (68%)  
 Sulfonylureas, n (%) 0 57 (38%)  
 Biguanide, n (%) 0 56 (38%)  
α-glucocitase inhibitor, n (%) 0 37 (25%)  
Pioglitazone, n (%) 0 22 (15%)  
Insulin, n (%) 0 45 (30%)  
DPP-4 inhibitor, n (%) 0 21 (14%)  
GLP-1 analog, n (%) 0 4 (3%)  
  1. BP, blood pressure; ASO, atherosclerotic obliterance; DPP-4, Dipeptidyl peptidase-4.
  2. Data are expressed as mean ± SD it as number (percentage).